NDC 43063-588

Methocarbamol

Methocarbamol

Methocarbamol is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Pd-rx Pharmaceuticals, Inc.. The primary component is Methocarbamol.

Product ID43063-588_7d4efb95-f335-3a91-e053-2991aa0aa55d
NDC43063-588
Product TypeHuman Prescription Drug
Proprietary NameMethocarbamol
Generic NameMethocarbamol
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2000-01-01
Marketing CategoryANDA / ANDA
Application NumberANDA085159
Labeler NamePD-Rx Pharmaceuticals, Inc.
Substance NameMETHOCARBAMOL
Active Ingredient Strength750 mg/1
Pharm ClassesCentrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 43063-588-20

20 TABLET in 1 BOTTLE, PLASTIC (43063-588-20)
Marketing Start Date2015-07-28
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 43063-588-90 [43063058890]

Methocarbamol TABLET
Marketing CategoryANDA
Application NumberANDA085159
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2016-12-14
Marketing End Date2019-09-19

NDC 43063-588-10 [43063058810]

Methocarbamol TABLET
Marketing CategoryANDA
Application NumberANDA085159
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2016-12-16
Marketing End Date2019-09-19

NDC 43063-588-20 [43063058820]

Methocarbamol TABLET
Marketing CategoryANDA
Application NumberANDA085159
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-07-28
Marketing End Date2019-09-19

NDC 43063-588-40 [43063058840]

Methocarbamol TABLET
Marketing CategoryANDA
Application NumberANDA085159
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-07-28
Marketing End Date2019-09-19

NDC 43063-588-14 [43063058814]

Methocarbamol TABLET
Marketing CategoryANDA
Application NumberANDA085159
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-07-28
Marketing End Date2019-09-19

NDC 43063-588-60 [43063058860]

Methocarbamol TABLET
Marketing CategoryANDA
Application NumberANDA085159
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-06-08
Marketing End Date2019-09-19

NDC 43063-588-15 [43063058815]

Methocarbamol TABLET
Marketing CategoryANDA
Application NumberANDA085159
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-07-28
Marketing End Date2019-09-19

NDC 43063-588-30 [43063058830]

Methocarbamol TABLET
Marketing CategoryANDA
Application NumberANDA085159
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-07-28
Marketing End Date2019-09-19

Drug Details

Active Ingredients

IngredientStrength
METHOCARBAMOL750 mg/1

OpenFDA Data

SPL SET ID:fdf45a23-06ee-4265-ae1c-81a0a4156d3f
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197944
    • UPC Code
  • 0343063588109

    • Pharmacological Class

    • Centrally-mediated Muscle Relaxation [PE]
    • Muscle Relaxant [EPC]

    NDC Crossover Matching brand name "Methocarbamol" or generic name "Methocarbamol"

    NDCBrand NameGeneric Name
    0143-1290MethocarbamolMethocarbamol
    0143-1292MethocarbamolMethocarbamol
    0179-0092MethocarbamolMethocarbamol
    0276-0510MethocarbamolMethocarbamol
    0404-9909MethocarbamolMethocarbamol
    0440-1740Methocarbamolmethocarbamol
    0517-1825Methocarbamolmethocarbamol
    0603-4485Methocarbamolmethocarbamol
    0603-4486Methocarbamolmethocarbamol
    0615-7572Methocarbamolmethocarbamol
    0615-7573Methocarbamolmethocarbamol
    0615-8435METHOCARBAMOLMETHOCARBAMOL
    0615-8436METHOCARBAMOLMETHOCARBAMOL
    0904-7057MethocarbamolMethocarbamol
    0904-7058MethocarbamolMethocarbamol
    10135-664MethocarbamolMethocarbamol
    10135-665MethocarbamolMethocarbamol
    10544-259MethocarbamolMethocarbamol
    10544-464MethocarbamolMethocarbamol
    10544-622MethocarbamolMethocarbamol
    10544-773MethocarbamolMethocarbamol
    10544-956Methocarbamolmethocarbamol
    17511-505METHOCARBAMOLMETHOCARBAMOL
    17511-506METHOCARBAMOLMETHOCARBAMOL
    21695-078MethocarbamolMethocarbamol
    21695-079MethocarbamolMethocarbamol
    68071-1874MethocarbamolMethocarbamol
    68071-4365MethocarbamolMethocarbamol
    68071-4458MethocarbamolMethocarbamol
    68071-4505MethocarbamolMethocarbamol
    68083-317MethocarbamolMethocarbamol
    68084-056MethocarbamolMethocarbamol
    68071-4520MethocarbamolMethocarbamol
    68084-057MethocarbamolMethocarbamol
    68151-2775MethocarbamolMethocarbamol
    68387-340MethocarbamolMethocarbamol
    68387-342MethocarbamolMethocarbamol
    68475-002MethocarbamolMethocarbamol
    68788-6391MethocarbamolMethocarbamol
    68788-9076MethocarbamolMethocarbamol
    68788-9075MethocarbamolMethocarbamol
    68788-9388MethocarbamolMethocarbamol
    68788-9768MethocarbamolMethocarbamol
    68788-9376MethocarbamolMethocarbamol
    69543-134MethocarbamolMethocarbamol
    69543-135MethocarbamolMethocarbamol
    70010-754MethocarbamolMethocarbamol
    70069-101MethocarbamolMethocarbamol
    70010-770MethocarbamolMethocarbamol
    70518-0024MethocarbamolMethocarbamol
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.